Mineralys Therapeutics, Inc.
USD27.09
+0.01 (+0.04%)
CEO
Jon Congleton
IPO Date
2023-02-10
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$26.53
Prev. Close
$27.08
Day Low
$26.44
Day High
$27.75
52W Low
$12.59
52W High
$47.65
Market Cap
$1.80B
Volume
0.60M
| 3,542 |
| $10.20 |
| 15 Jul 2026 | Rodman David Malcom | Chief Medical Officer | M-Exempt | Acquired | 4,167 | $14.25 |
| 15 Jul 2026 | Rodman David Malcom | Chief Medical Officer | M-Exempt | Acquired | 6,349 | $1.08 |
| 15 Jul 2026 | Rodman David Malcom | Chief Medical Officer | S-Sale | Disposed | 14,058 | $27.58 |
| 15 Jul 2026 | Rodman David Malcom | Chief Medical Officer | S-Sale | Disposed | 6,349 | $26.61 |
| 15 Jul 2026 | Rodman David Malcom | Chief Medical Officer | M-Exempt | Disposed | 3,542 | $10.20 |
| 15 Jul 2026 | Rodman David Malcom | Chief Medical Officer | M-Exempt | Disposed | 4,167 | $14.25 |
| 15 Jul 2026 | Rodman David Malcom | Chief Medical Officer | M-Exempt | Disposed | 6,349 | $1.08 |
| 10 Jul 2026 | Rodman David Malcom | Chief Medical Officer | M-Exempt | Acquired | 2,171 | $16.00 |